With only weeks to go, are we ready for Brexit?

brexit_big

With a matter of weeks to go until the UK is due to leave the European Union, negotiations between warring factions in the British political establishment threaten to derail any prospect of a staged, sensibly managed exit process.

While UK Prime Minister Theresa May has presented a plan, agreed with the EU, for a 20 month “transition period” - under which many of the rules of trade would remain the same, allowing time for further discussion on a permanent settlement - that deal remains in limbo, after being roundly rejected by the British Parliament last month.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Company Spotlight



More Features in Pharmaceutical